{"database": "lobbying", "table": "lobbying_activities", "rows": [[2466899, "9b1044e2-1099-488f-9a30-52c831f0a010", "Q2", "PUBLIC CITIZEN", 32362, "PUBLIC CITIZEN", 2020, "second_quarter", "PHA", "Access to coronavirus treatments and vaccines, COVID-19 medicine pricing and access, COVID-19 Emergency manufacturing act, transparency for federally support COVID R&D, Pharmaceuticals and antitrust", "Consumer Product Safety Commission (CPSC),HOUSE OF REPRESENTATIVES,Securities & Exchange Commission (SEC),SENATE,White House Office", null, 110000, 0, 0, "2020-07-15T16:15:19.427000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2466899"], "units": {}, "query_ms": 50.931302015669644, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}